REMRemgro Limited

🇿🇦 Güney Afrika Borsası
19080.00
ZAR
Analysis Scores
Lothien Robustness Score?
49/100
Moderate
Neden bu skor?
Damodaran ?
16/100
Dalio Risk ?
91/100
Piotroski ?
8/9
Strong
Graham ?
R169.4
Pahalı
Active Metric?
4/4
Confidence?
72%
Valuation
Potential?
-26.2%
ROIC ?
2.4%
DCF Value ?
56.42
Debt Cycle?
Early Expansion
Data
Data ?
6824
2000-01-04 → 2026-09-02
Risk Analysis (VaR) Düşük
252 days
Annual Volatility ?
%19.7
VaR 95% ?
%1.99
daily max loss
VaR 99% ?
%2.84
daily max loss
CVaR 95% ?
%2.44
expected loss (tail)
Max Drawdown ?
%9.0
08.04.2026 → 10.06.2026
Skewness ?
0.28
Parametrik%1.99
Historik%1.71
Cornish-Fisher%1.84
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Near TRAMA
Price (19080.00), TRAMA-99 line (18476.35) at close levels (%+3.3). Important decision zone — breakout direction will determine the trend.
Price:: 19080.0
TRAMA: 18476.3507
Difference: %+3.3
Profitability
Net Profit Margin %6.2
Net profit margin %6.2 — positive but low. Compared to previous quarter +0.0 point increase.
ROE – Özkaynak Getirisi (TTM) %1.4
ROE %1.4 — low return on equity.
EBITDA Margin %8.2
EBITDA margin %8.2 — moderate operational efficiency.
Gross Profit Margin %26.6
Gross profit per revenue %26.6. Evaluate relative to sector.
Free Cash Flow Margin (TTM) %5.7
TTM Free Cash Flow is %5.7'i. Moderate FCF — capex constraining operational profit.
Valuation
P/E Ratio 32.1x Sector: 11.6x
F/K 32.1x — sector median's (11.6x) %178 above. Expensive zone.
P/B Ratio 0.89x Sector: 1.44x
PD/DD 0.89x — sector median's (1.44x) çok below. Defter değerine göre undervalued.
EV/EBITDA 23.4x Sector: 5.7x
EV/EBITDA 23.4x — sector median's (5.7x) %311 above. EBITDA’ya göre pahalı.
Indebtedness
Current Ratio 3.51x
Current ratio 3.51x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA 1.2x
Net Borç/EBITDA 1.2x — very low debt burden. Company can repay debt quickly.
Debt / Equity 0.04x
Low leverage — majority of assets financed by equity.
Interest Coverage 10.5x
Interest coverage 10.5x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY) %+1.1
Revenue YoY %1.1 grew — positive but slow growth.
Net Profit Growth (YoY) %+166.2
Net profit YoY %166.2 increased (2025/12) — extraordinary profit growth.
Score Explanations
Lothien Robustness
49/100
Moderate robustness (49/100). Valuation and risk criteria give mixed signals. Detailed review recommended.
Moderate
Potential
-26.2%
Minus %26.2 expected value (14084.19) vs current price comparison. 4/4 valuation models give 'BUY' signal. Model confidence %72.
Components: PE target: 7344.77 | P/B target: 31165.79 | EV/EBITDA target: 4770.00 | DCF target: 4770.00
Damodaran Valuation
16/100
Low Damodaran score (16/100). ROIC (%2.4) below cost of capital. DCF analysis does not support current price.
Very Weak
Dalio Risk Analysis
91/100
Low debt risk (91/100). Interest coverage ratio 10.5x — strong. Borç/EBITDA 1.2x — in healthy range.
Leverage: 92/100 | Debt Service: 100/100 | Quality: 72/100
ROIC – Sermaye Getirisi
%2.4
ROIC (%2.4) cost of capitaln (17.8%) below → destroying value.
WACC: %17.8
DCF Discounted Cash Flow
56.42
DCF (56.42) current price %99.7 below — cash flows do not support current price.
Current price: 19080.00
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
8/9
Strong Piotroski F-Score (8/9). Profitability, leverage and operational efficiency criteria are largely met.
Strong
Graham Intrinsic Value
R169.4
Graham intrinsic value: R169.4. Pahalı
Expensive
⚖️ Sector Comparison
P/E Ratio
32.1x vs 11.6x
Sector mediannın %178 above — expensive
P/B Ratio
0.89x vs 1.44x
Compared to sector %38 cheaper (by book value)
EV/EBITDA
23.4x vs 5.7x
Compared to sector %311 higher EV/EBITDA
ROIC vs WACC
%2.4 vs %17.8 WACC
ROIC 15.4 baz puan cost of capitaln altında
Net Profit Margin (TTM)
%6.2 vs %8.2 EBITDA margin
TTM net profit margin %6.2
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
REM — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.
A
AirSelim
Online
A
Hello! I am AirSelim, your Lothien finance assistant.

I can answer questions about market data, news, technical analysis, portfolio analysis and more.

I cover 26 exchanges (BIST, US, LSE, Xetra, Tadawul, KASE and others) — plus crypto.